跳至主要内容
临床试验/TCTR20220406001
TCTR20220406001已完成4 期

Targeted-low-volume versus High-volume local infiltration analgesia for postoperative analgesia after total knee arthroplasty: A randomized non-inferiority trial

/A0 个研究点目标入组 139 人开始时间: 2022年4月6日最近更新:
适应症

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
139

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
50 Years 至 80 Years(—)
性别
All

入选标准

  • •Patients scheduled for total knee arthroplasty at King Chulalongkorn Memorial Hospital
  • •ASA class 1 to 3
  • •Body mass index (BMI )between 18 to 40 kg/m2

排除标准

  • •1. refuse to participate this study
  • •2. unable to cooperate or cognitive impairment
  • •3. allergy to any drug in this study
  • •4. contraindication to neuraxial anesthesia
  • •5. contraindication to NSAIDs Ketorolac and Celebrex
  • •6. chronic opioids use or diagnosed of neuropathic pain
  • •7. unable to performed Time up and go test
  • •8. undergo bilateral knee arthroplasty in the same operation

研究者

发起方
/A

相似试验